REFERÊNCIAS BIBLIOGRÁFICAS
7. REFERÊNCIAS BIBLIOGRÁFICAS
Adams J, Elliot PJ, New Agents in Cancer Clinical Trials, Oncogene 56 (2000) 66876692.
Anker P, Stroun M., Circulating DNA in plasma or serum, Medicina (B Aires).
60(2000) 699-702, Review.
Baak JP, Path FR, Hermsen MA, Meijer G, Schmidt J, Janssen EA, Genomics and
proteomics in cancer, Eur J Cancer. 39 (2003) 1199-215.
Beljanski M, Bourgarel P, Beljanski M., Correlation between in vitro DNA synthesis,
DNA strand separation and in vivo multiplication of cancer cells, Exp Cell Biol.
49(1981) 220-31.
Bishop JM. The molecular genetics of cancer. Science 235 (1987) 305-311.
Brennan DJ, O'Brien SL, Fagan A, Culhane AC, Higgins DG, Duffy MJ, Gallagher
WM., Application of DNA microarray technology in determining breast cancer
prognosis and therapeutic response, Expert Opin Biol Ther. 5(2005) 1069-83.
Brennan P., Gene-environment interaction and aetiology of cancer: what does it mean
and how can we measure it?, Carcinogenesis 23(2002) 381-7.
QUANTIFICAÇÃO DE DNA PLASMÁTICO EM PACIENTES COM CANCRO DA MAMA
68
REFERÊNCIAS BIBLIOGRÁFICAS
Carter CL, Allen C, Henson DE., Relation of tumor size, lymph node status, and
survival in 24,740 breast cancer cases, Cancer. 63(1989) 181-7.
Cianfrocca M, Flatters SJ, Bennett GJ, McNicol E, Relias V, Carr D, Gillis TA.,
Peripheral neuropathy in a woman with breast cancer, J Pain. 7(2006) 2-10.
Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S, Boyle P., Overview of
the main outcomes in breast-cancer prevention trials, Lancet 361(2003) 296-300,
Review.
Dickson RB, Lippman ME, Cancer of the breast, In Cancer: Principles and practice of
th
oncology, 6 edition (eds DeVita VT, Hellman S, Rosenberg SA), Lippincott Williams
and Williams, (2001) 1652, USA.
Dirix LY, Salgado R, Weytjens R, Colpaert C, Benoy I, Huget P, van Dam P, Prove A,
Lemmens J, Vermeulen P., Plasma fibrin D-dimer levels correlate with tumour volume,
progression rate and survival in patients with metastatic breast cancer, Br J Cancer.
86(2002) 389-95.
Esteller, M., Sanches-Cespedes, M., et al, Detection of aberrant promoter
hypermethilation of tumor suppressor genes in serum DNA from non-small cell lung
cancer patients, Cancer Res. 59 (1999) 67-70.
QUANTIFICAÇÃO DE DNA PLASMÁTICO EM PACIENTES COM CANCRO DA MAMA
69
REFERÊNCIAS BIBLIOGRÁFICAS
Fanci, Braunwald, Isselacher, Wilson, Martin, Kasper, Hauser, Longo, Harrison`s –
Principles of Internal Medicine 16ª ed, Mc Graw Hill (2006)
Farin Kamangar, Graça M. Dores, et al, Patterns of Cancer Incidence, Mortality, and
Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in
Different Geographic Regions of the World, J Clin Oncol 24 (2006) 2139-2145.
Fiegl H, Millinger S, Mueller-Holzner E, Marth C, Ensinger C, Berger A, Klocker H,
Goebel G, Circulating tumor-specific DNA: a marker for monitoring efficacy of
adjuvant therapy in cancer patients, Cancer Res. 65(2005) 1141-5.
Feigelson HS, Henderson BE., Future possibilities in the prevention of breast cancer:
role of genetic variation in breast cancer prevention, Breast Cancer Res. 2(2000) 27782, Review.
Ferlay A, Charret C, Galitzky J, Berlan M, Chilliard Y., Effects of the perfusion of beta
,beta2-, or beta3-adrenergic agonists or epinephrine on in situ adipose tissue lipolysis
measured by microdialysis in underfed ewes, J Anim Sci. 79(2001) 453-62.
Fournie GJ, Courtin JP, Laval F, Chale J, Pourrat J, Pujazon M, Lauque D, Carles P.,
Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering
from lung cancer and in nude mice bearing human tumours, Cancer Lett. 91(1995)
2217.
QUANTIFICAÇÃO DE DNA PLASMÁTICO EM PACIENTES COM CANCRO DA MAMA
70
REFERÊNCIAS BIBLIOGRÁFICAS
Fuszek P, Lakatos P, Tabak A, et al, Significance of serum calcium levels in colorectal
cancer, Orv. Hetil 30 (2004) 1561-1565.
Gaballah HE, Abdel Salam I, Abdel Wahab N, Mansour OM., Plasma bcl-2 and nitric
oxide: possible prognostic role in patients with metastatic breast cancer, Med Oncol.
18(2001) 171-8.
Gautschi O, Bigosch C, Huegli B, Jermann M, Marx A, Chasse E, Ratschiller D, Weder
W, Joerger M, Betticher DC, Stahel RA, Ziegler A., Circulating deoxyribonucleic Acid
as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy, J
Clin Oncol. 22(2004) 4157-64.
Gilbey AM, Burnett D, Coleman RE, Holen I, The detection of circulating breast cancer
cells in blood, J. Clin. Pathol., 57 (2004) 903-911.
Goessl C, Heicappell R, Munker R, Anker P, Stroun M, Krause H, Muller M, Miller K.,
Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma,
Cancer Res. 58(1998) 4728-32.
Hanahan D, Weinberg RA., The hallmarks of cancer, Cell. 100(2000) 57-70, Review.
Hayes DF., Prognostic and predictive factors revisited, Breast. 14(2005) 493-9, Review.
QUANTIFICAÇÃO DE DNA PLASMÁTICO EM PACIENTES COM CANCRO DA MAMA
71
REFERÊNCIAS BIBLIOGRÁFICAS
Hayes JC., Canadian study once again challenges breast screening, Diagn Imaging (San
Franc), 22(2000) 31-2.
Hibi K, Robinson CR, Booker S, Wu L, Hamilton SR, Sidransky D, Jen J., Molecular
detection of genetic alterations in the serum of colorectal cancer patients., Cancer Res.
58(1998) 1405-7.
Houssami N, Wilson R., Should women at high risk of breast cancer have screening
magnetic resonance imaging (MRI)?, reast. 16(2007) 2-4.
Johnson PJ, Lo YM, Plasma nucleic acids in the diagnosis and managment of malignant
disease, Clin. Chem. 48 (2002) 1186-1193.
Kumar R,Bozkurt MF,Zhuang H,Alavi A, Sentinel lymph node biopsy in the
management of breast cancer, Indian J Cancer 40 (2003) 60-6.
Leon SA, Green A, Yaros MJ, Shapiro B, Radioimmunoassay for nanogram quantities
of DNA, J Immunol Methods. 9(1975) 157-64.
Leon SA, Shapiro B, Sklaroff DM, Yaros MJ., Free DNA in the serum of cancer
patients and the effect of therapy, Cancer Res. 37(1977) 646-50.
Li ZJ, Hillyard D, Higgins P., Nucleotide sequence of the Salmonella typhimurium
himA gene, Nucleic Acids Res. 17(1989) 8880.
QUANTIFICAÇÃO DE DNA PLASMÁTICO EM PACIENTES COM CANCRO DA MAMA
72
REFERÊNCIAS BIBLIOGRÁFICAS
Liotta LA, Liu ET. Essentials of Molecular Biology: Genomics and Cancer. In Cancer:
th
Principles and practice of oncology, 6 edition (eds DeVita VT, Hellman S, Rosenberg
SA); Lippincott Williams and Williams 17 (2001), USA.
Lv J, Liu H, Wang Q, Tang Z, Hou L, Zhang B., Molecular cloning of a novel human
gene encoding histone acetyltransferase-like protein involved in transcriptional
activation of hTERT, Biochem Biophys Res Commun. 311(2003) 506-13.
Mandel P, Métais P., Les acides nucléiques du plasma sanguin chez l’homme, CR Acad
Sci Paris 142 (1948) 241-243.
Martin M., Molecular biology of breast cancer, Clin Transl Oncol. 8(2006) 7-14,
Review.
Massacesi C, Rocchi MB, Marcucci F, Pilone A, Galleazi M, Serum tumor markers
may precede instrumental response to chemotherapy in patients with metastic cancer,
Int. J. Biol. Markers 18 (2003) 295-300.
Mehes G, Witt A, Kubista E, Ambros PF., Circulating breast cancer cells are frequently
apoptotic, Am J Pathol. 159(2001) 17-20.
Molnar B, Sipos F, Galamb O, Tulassay Z., Molecular detection of circulating cancer
cells. Role in diagnosis, prognosis and follow-up of colon cancer patients,
QUANTIFICAÇÃO DE DNA PLASMÁTICO EM PACIENTES COM CANCRO DA MAMA
73
REFERÊNCIAS BIBLIOGRÁFICAS
Dig Dis. 21(2003) 320-5, Review.
Parkin D.M., Global cancer statistics in the year 2000, The lancet oncology 2 (2001)
533-43.
Pinheiro PS, Tyczynski JE, Bray F, Amado J, Matos E, Miranda AC, Limbert E, Cancer
in Portugal, IARC Technical Publication No 38 (2002), Lyon, Paris.
Pinheiro PS,Tyczynski JE,Bray F,Amado J,Matos E,Parkin DM, Cancer incidence and
mortality in Portugal, Eur J Câncer, 39 (2003) 2507-20.
Raptis L, Menard HA., Quantitation and characterization of plasma DNA in normals
and patients with systemic lupus erythematosus, J Clin Invest. 66(1980) 1391-9.
Roses DF, Brooks AD, Harris MN, Shapiro RL, Mitnick J., Complications of level I
and II axillary dissection in the treatment of carcinoma of the breast, Ann Surg.
230(1999) 194-201.
Sanchez-Cespedes M, Reed AL, Buta M, Wu L, Westra WH, Herman JG, Yang SC, Jen
J, Sidransky D., Inactivation of the INK4A/ARF locus frequently coexists with TP53
mutations in non-small cell lung cancer, Oncogene. 18(1999) 5843-9.
QUANTIFICAÇÃO DE DNA PLASMÁTICO EM PACIENTES COM CANCRO DA MAMA
74
REFERÊNCIAS BIBLIOGRÁFICAS
Schwarzenbach H, Muller V, Stahmann N, Pantel K., Detection and characterization of
circulating microsatellite-DNA in blood of patients with breast cancer, Ann N Y Acad
Sci. 1022 (2004) 25-32.
Seker D, Kaya O, Adabag A, Necipoglu G, Baran I., Role of preoperative plasma CA
15-3 and carcinoembryonic antigen levels in determining histopathologic conventional
prognostic factors for breast cancer, World J Surg. 27(2003) 519-21.
Shapiro B., Chakrabarty M., Cohn EM, et al, Determination of circulating DNA levels
in patients with benign or malignant gastrointestinal disease, Cancer 51 (1983) 21162120.
Shaw JA, Smith BM, Walsh T, Johnson S, Primrose L, Slade MJ, Walker RA, Coombes
RC., Microsatellite alterations plasma DNA of primary breast cancer patients, Clin
Cancer Res. 6(2000) 1119-24.
Shields PG, Harris CC., Molecular epidemiology and the genetics of environmental
cancer, JAMA. 266(1991) 681-7, Review 11.
Silva JM, Dominguez G, Silva J, Garcia JM, Sanchez A, Rodriguez O, Provencio M,
Espana P, Bonilla F., Detection of epithelial messenger RNA in the plasma of breast
cancer patients is associated with poor prognosis tumor characteristics, Clin Cancer Res.
7(2001) 2821-5.
QUANTIFICAÇÃO DE DNA PLASMÁTICO EM PACIENTES COM CANCRO DA MAMA
75
REFERÊNCIAS BIBLIOGRÁFICAS
Silva JM, Gonzalez R, Dominguez G, Garcia JM, Espana P, Bonilla F., TP53 gene
mutations in plasma DNA of cancer patients, Genes Chromosomes Cancer. 24(1999)
160-1.
Silva JM, Silva J, Sanchez A, Garcia JM, Dominguez G, Provencio M, Sanfrutos L,
Jareno E, Colas A, Espana P, Bonilla F., Tumor DNA in plasma at diagnosis of breast
cancer patients is a valuable predictor of disease-free survival, Clin Cancer Res. 8(2002)
3761-6.
Sonobe M, Tanaka F, Wada H., Lung cancer-related genes in the blood, Ann Thorac
Cardiovasc Surg. 10(2004) 213-7, Review.
Sozzi, G., Conte, D., Leon, M., et al, Quantification of free circulating DNA as a
diagnostic marker in lung cancer, Journal of Clinical Oncology, 21 (2003) 3902-3907.
Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C, Beljanski M., Neoplastic
characteristics of the DNA found in the plasma of cancer patients, Oncology. 46(1989)
318-22.
Stewart BW and Kleihues World Cancer Report. IARC Press (2003), Lyon.
Stevanovic A, Lee P, Wilken N, Metastic Breast Cancer, Aust. Fam. Physician, 35
(2006) 309-312.
QUANTIFICAÇÃO DE DNA PLASMÁTICO EM PACIENTES COM CANCRO DA MAMA
76
REFERÊNCIAS BIBLIOGRÁFICAS
Sussman LK, Upalakalin JN, Roberts MJ, Kocher O, Benjamin LE., Blood markers for
vasculogenesis increase with tumor progression in patients with breast carcinoma,
Cancer Biol Ther. 2(2003) 255-6.
Stroun M, Lyautey J, Lederrey C, Mulcahy HE, Anker P., Alu repeat sequences are
present in increased proportions compared to a unique gene in plasma/serum DNA:
evidence for a preferential release from viable cells?, Ann N Y Acad Sci. 945 (2001)
258-64.
Swain SM, Rowland J, Weinfurt K, Berg C, Lippman ME, Walton L, Egan E, King D,
Spertus I, Honig SF., Intensive outpatient adjuvant therapy for breast cancer: results of
dose escalation and quality of life, J Clin Oncol. 14(1996) 1565-72.
Tan EM, Schur PH, Carr RI, Kunkel HG., Deoxybonucleic acid (DNA) and antibodies
to DNA in the serum of patients with systemic lupus erythematosus, J Clin Invest.
45(1966) 1732-40.
Taback B, Giuliano AE, Hansen NM, Singer FR, Shu S, Hoon DS., Detection of tumorspecific genetic alterations in bone marrow from early-stage breast cancer patients,
Cancer Res. 63(2003) 1884-7.
Volgestein B, Kinzler KW, The genetic basis of human cancer, McGraw-Hill, (1998),
USA.
QUANTIFICAÇÃO DE DNA PLASMÁTICO EM PACIENTES COM CANCRO DA MAMA
77
REFERÊNCIAS BIBLIOGRÁFICAS
Vasioukhin V, Anker P, Maurice P, Lyautey J, Lederrey C, Stroun M., Point mutations
of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome
or acute myelogenous leukaemia, Br J Haematol. 86(1994) 774-9.
Wang BG, Huang HY, Chen YC, Bristow RE, Kassauei K, Cheng CC, Roden R, Sokoll
LJ, Chan DW, Shih IeM., Increased plasma DNA integrity in cancer patients, Cancer
Res. 63(2003) 3966-8.
Weber JL, David D, Heil J, Fan Y, Zhao C, Marth G., Human Diallelic
Insertion/Deletion Polymorphisms, Am J Hum Genet. 71 (2002) 854-862.
Wong IH, Lo YM, Zhang J, Liew CT, Ng MH, Wong N, Lai PB, Lau WY, Hjelm NM,
Johnson PJ., Detection of aberrant p16 methylation in the plasma and serum of liver
cancer patients, Cancer Res. 59(1999) 71-3.
Wu TL, Zhang D, Chia JH, Tsao KH, Sun CF, Wu JT., Cell-free DNA:measurement in
various carcinomas and establishment of normal reference range, Clin Chim Acta.
321(2002) 77-87.
QUANTIFICAÇÃO DE DNA PLASMÁTICO EM PACIENTES COM CANCRO DA MAMA
78